1147077-82-4

Basic information

• Product Name: 2-amino-8-methyl-4-phenyl-5H-indeno[1,2-d]pyrimidin-5-one
• Synonyms: 2-amino-8-methyl-4-phenyl-5H-indeno[1,2-d]pyrimidin-5-one
• CAS NO: 1147077-82-4
• Molecular Weight: 287.321
• Mol File: 1147077-82-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-amino-8-methyl-4-phenyl-5H-indeno[1,2-d]pyrimidin-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-amino-8-methyl-4-phenyl-5H-indeno[1,2-d]pyrimidin-5-one(1147077-82-4)
• EPA Substance Registry System: 2-amino-8-methyl-4-phenyl-5H-indeno[1,2-d]pyrimidin-5-one(1147077-82-4)

Safety Data

• Hazardous Substances Data: 1147077-82-4(Hazardous Substances Data)

Upstream product

• 60031-11-0 2-benzylidene-6-methylindan-1-one 
• 100-52-7 benzaldehyde 
• 50-01-1 guanidine hydrochloride 
• 24623-20-9 2,3-dihydro-6-methyl-1H-inden-1-one 

Downstream Products

• 1147077-78-8 C₂₈H₂₈BrN₃O₅ 
• 1147271-26-8 2-amino-8-(bromomethyl)-4-phenyl-5H-indeno[1,2-d]-pyrimidin-5-one 
• 1228035-41-3 2-amino-4-phenyl-8-(pyrrolidin-1-ylmethyl)-5H-indeno[1,2-d]-pyrimidin-5-one 
• 1147077-77-7 C₂₈H₂₉N₃O₅ 

Relevant articles and documents

ARYLINDENOPYRIMIDINES FOR TREATING NEURODEGENERATIVE AND MOVEMENT DISORDERS WHILE MINIMIZING CARDIAC TOXICITY

This invention provides novel arylindenopyrimidines of the Formula (I), and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A1 and/or A2a receptors. This invention also provides therapeutic

In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease

The in vivo characterization of a dual adenosine A2A/A 1 receptor antagonist in several animal models of Parkinson's disease is described. Discovery and scale-up syntheses of compound 1 are described in detail, highlighting optimizat